MediPharm Labs’ state-of-the-art cannabis extraction facility is Good Manufacturing Practices (GMP) Certified and designed with ISO standard cleanrooms and critical environments.
Our strict manufacturing standards result in pharma-quality cannabis API and derivative products for patients and consumers that are pure, trusted and precisely dosable.
Our Mission
To be a trusted global leader in the industrial-scale manufacturing of high-quality, cannabinoid-based derivatives by utilizing industry-leading practices, purpose-built facilities, and an expert-backed research team.
MediPharm Labs aims to bring a pharmaceutical perspective to the cannabis industry. Working to internationally recognized pharma-quality standards, we strive to provide top cannabis products that are pure, trusted and precisely dosable for patients and end consumers.
Our Operations
All MediPharm Labs’ product offerings begin with quality sourced and validated dried cannabis. We focus on four core standards: a stable supply chain of legal producers, highly vetted and safe product standards, reliable and consistent cultivars, and full suite of testing on every single batch of cannabis oil and finished goods.
Through wholesale and white label platforms from its GMP-certified facilities, MediPharm Labs formulates, tests, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets.
Our Facility
MediPharm Labs Canada is based out of its state of the art 70,000 sq. ft. facility in Barrie, Ontario. Utilizing a GMP certified space and ISO standard built clean rooms, we are committed to manufacture products of the highest quality and exceed regulatory requirements.
Further National Health-Service Information on